Community Academic Profiles–

Katrin Andreasson

Back to Profile

Publication Details

  • Trial of celecoxib in amyotrophic lateral sclerosis.

    Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB. Ann Neurol. 2006; 60 (1): 22-31

    To determine whether chronic treatment with celecoxib, a cyclooxygenase-2 inhibitor that has been shown to be beneficial in preclinical testing, is safe and effective in amyotrophic lateral sclerosis (ALS).

    PubMedID: 16802291

Stanford Medicine Resources:

Footer Links: